• 1. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate (CAS No. 1211511-34-0): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate (CAS No. 1211511-34-0) is a highly versatile and significant intermediate in the field of pharmaceutical synthesis. This compound, characterized by its pyrimidine core structure, has garnered considerable attention due to its utility in the development of various therapeutic agents. The presence of both chloro and methyl substituents on the pyrimidine ring enhances its reactivity, making it a valuable building block for medicinal chemists.

The chemical structure of Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate consists of a six-membered heterocyclic ring containing nitrogen atoms, which is a hallmark of pyrimidine derivatives. The chloro group at the 6-position and the methyl group at the 5-position contribute to its unique chemical properties, enabling diverse functionalization strategies. These features make it an indispensable component in the synthesis of biologically active molecules.

In recent years, there has been a surge in research focusing on pyrimidine derivatives due to their broad spectrum of biological activities. Pyrimidines are fundamental components of nucleic acids, and their derivatives have been extensively explored for their pharmacological properties. Among these, Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate has emerged as a crucial intermediate in the synthesis of antiviral, anticancer, and anti-inflammatory agents.

One of the most compelling applications of Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate is in the development of antiviral drugs. The pyrimidine scaffold is closely related to the natural nucleobases found in DNA and RNA, making it an ideal candidate for inhibiting viral replication. Recent studies have demonstrated that derivatives of this compound can effectively interfere with viral polymerase enzymes, thereby reducing viral load in infected individuals. This has opened up new avenues for the treatment of emerging viral infections.

The anticancer potential of Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate has also been extensively studied. Pyrimidine-based compounds have shown promise in targeting various cancer pathways, including DNA replication and cell cycle regulation. Researchers have synthesized numerous analogs of this compound, which exhibit potent cytotoxic effects against a wide range of cancer cell lines. Some of these derivatives have even entered clinical trials, showcasing their potential as novel chemotherapeutic agents.

In addition to its role in antiviral and anticancer therapies, Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate has been explored for its anti-inflammatory properties. Inflammation is a key factor in many chronic diseases, and inhibiting inflammatory pathways can lead to significant therapeutic benefits. Pyrimidine derivatives have been shown to modulate inflammatory responses by interacting with various signaling molecules. This has prompted researchers to investigate Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate as a potential lead compound for developing anti-inflammatory drugs.

The synthetic utility of Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate extends beyond pharmaceutical applications. It serves as a valuable intermediate in the synthesis of agrochemicals and specialty chemicals. The versatility of its structure allows for further functionalization, enabling the production of compounds with tailored properties for various industrial uses.

The growing demand for Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate has spurred advancements in synthetic methodologies aimed at improving its production efficiency and scalability. Modern synthetic approaches focus on optimizing reaction conditions to minimize waste and maximize yield while maintaining high purity standards. These efforts are crucial for ensuring a steady supply of this compound to meet the increasing demands of the pharmaceutical industry.

In conclusion, Methyl 6-chloro-5-methyl-4-pyrimidinecarboxylate (CAS No. 1211511-34-0) is a pivotal intermediate with far-reaching implications in pharmaceutical research and development. Its unique structural features and broad range of applications make it an indispensable tool for medicinal chemists working on antiviral, anticancer, anti-inflammatory, and other therapeutic agents. As research continues to uncover new biological activities and synthetic possibilities, this compound will undoubtedly remain at the forefront of drug discovery efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)